Superiority of Micrococcus lysodeikticus to BCG in chemo-immunotherapy of advanced L1210 leukaemia
- PMID: 6799298
- DOI: 10.1016/0014-2964(81)90304-2
Superiority of Micrococcus lysodeikticus to BCG in chemo-immunotherapy of advanced L1210 leukaemia
Similar articles
-
Successful immunotherapy with micrococcus, BCG or related polysaccharides on L1210 leukaemia after BCNU chemotherapy.Br J Cancer. 1981 Feb;43(2):201-9. doi: 10.1038/bjc.1981.29. Br J Cancer. 1981. PMID: 7470382 Free PMC article.
-
Comparison between the effects of Micrococcus, BCG and related polysaccharides in preclinical chemo-immunotherapy of murine L 1210 leukaemia [proceedings].Arch Int Physiol Biochim. 1978 Oct;86(4):969-71. Arch Int Physiol Biochim. 1978. PMID: 84653 No abstract available.
-
Influence of micrococcus, BCG and related polysaccharides on the proliferation of the L1210 leukaemia.Br J Cancer. 1978 Nov;38(5):599-605. doi: 10.1038/bjc.1978.255. Br J Cancer. 1978. PMID: 728349 Free PMC article.
-
Immunotherapy of leukaemia.Schweiz Med Wochenschr. 1974 May 4;104(18):626-33. Schweiz Med Wochenschr. 1974. PMID: 4596725 Review. No abstract available.
-
Discussion paper: experimental and clinical immunopharmacology data applicable to cancer immunotherapy.Ann N Y Acad Sci. 1976;277(00):467-84. doi: 10.1111/j.1749-6632.1976.tb41721.x. Ann N Y Acad Sci. 1976. PMID: 826207 Review. No abstract available.